Introduction
Stat3, the major mediator of IL-6 signaling, 1, 2 participates in cellular transformation and oncogenesis. 3, 4 Its activation is essential for the transforming potential of many oncogenes.
Previously, we could show that Stat3 activation is required for IL-6-dependent growth and survival of the human myeloma cell lines INA-6 and XG-1. 5 Although microarray analyses revealed that in these cells the vast majority of IL-6 target genes is controlled through Stat3, differential expression of known apoptosis regulators, e.g. members of the Bcl-2 family, could not sufficiently account for the observed Stat3-mediated survival effect. 5 We therefore searched for additional mechanisms through which Stat3 may suppress apoptosis in cancer cells.
MicroRNAs (miRNAs) are an abundant class of short non-protein-coding RNAs (ncRNAs) mediating posttranscriptional down-regulation of target genes. They have been shown to play a fundamental role in diverse physiological and pathological processes including proliferation, apoptosis, differentiation, and cell fate determination. 6, 7 Recent evidence indicates that miRNAs can function as tumor suppressors and oncogenes. 8 Hence, we reasoned that miRNAs might be implicated in the Stat3-mediated survival of myeloma cells.
Materials and Methods
A detailed description of the bioinformatic procedures and the vectors and primer sequences used is given as supplemental material.
INA-6 and XG-1 myeloma and HepG2 hepatocellular carcinoma cells were cultivated and reporter gene assays performed as recently described. 5, 9 Chromatin immunoprecipitation was performed using a kit (EZ ChIP) from Upstate (Lake Placid, NY, USA) according to the manufacturer's instructions. Co-immunoprecipitated DNA was amplified using primers specific for the miR-21 upstream region and analysed on an agarose gel.
Anti-Stat3 serum (PA-ST3) was from R&D Systems (Wiesbaden, Germany).
RNA interference knock-down of Stat3 and overexpression of miR-21 in myeloma cells was performed by electroporation with pSUPER vectors as described. Apoptosis was detected by flow-cytometry using annexin-V staining as previously described.
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Results and Discussion
To investigate whether Stat3 is involved in the regulation of miRNA genes, we analysed the Genomic data suggest that miR-21 and its associated Stat3 binding sites are functionally independent of TMEM49 (supplemental Table S1 ). A stable distance between miR-21 and the Stat3 sites throughout all vertebrates strongly suggests their functional correlation (supplemental Fig. S1 ).
Löffler et al. 6 Chromatin immunoprecipitation revealed that Stat3 is indeed recruited to the miR-21 upstream region in XG-1 human myeloma cells in response to IL-6 (Fig. 1B) . Furthermore, a genomic DNA fragment extending from -1120 to +25 bp relative to the miR-21 transcription start site 14 and containing the putative Stat3 enhancer region proved to be IL-6-responsive in a reporter assay (Fig. 1C) . IL-6-induced miR-21 promoter activity was abolished when the Stat3 motifs were eliminated by site-directed mutagenesis. Likewise, knocking down Stat3 by RNA interference inhibited miR-21 promoter activity. The effects of Stat3 knockdown could be rescued by expression of an siRNA-resistant variant of Stat3 (supplemental Fig. S2 ). These data Since miR-21 is involved in the control of tumor cell apoptosis [11] [12] [13] we reasoned that it might contribute to the Stat3-dependent survival of myeloma cells. Due to relatively high basal miR-21 expression levels, a miR-21 knock-down might cause effects that go beyond Stat3 regulation.
Therefore, we chose to ectopically elevate miR-21 expression in the absence of IL-6 to levels comparable to those observed in response to Stat3 activation. Upon electroporation of INA-6 cells with a miR-21 expression vector and sorting the transfected cells, we determined a 2.4-fold increase in mature miR-21 expression over endogenous levels by real-time PCR analysis (mean of three independent experiments). As reported earlier, 5 IL-6 withdrawal rapidly induced apoptosis in INA-6 cells (Fig. 2D) . Raising miR-21 expression, however, yielded significantly higher levels of non-apoptotic cells (Fig. 2E ). This effect was most dramatic in the absence of IL-6, reducing the cytokine-dependency of the INA-6 cells. all of which contain constitutively activated Stat3 or even rely on Stat3 with respect to cell survival or growth. 11, 12, 15, 16, 22 Taken together, our observations strongly suggest a pivotal relevance of miR-21 for the oncogenic potential of Stat3 and thereby for its involvement in the pathogenesis of multiple myeloma and other malignancies.
Since miRNAs function as negative regulators of the stability and/or translation of specific target mRNAs, an important step to unravel the molecular mechanism of miR-21 action will be to identify its mRNA targets. Recently, miR-21 was reported to repress the expression of the tumor suppressor PTEN. 12 Yet, we did not detect upregulation of PTEN expression or AKT phosphorylation in INA-6 and XG-1 cells in response to IL-6 (data not shown).
Stat3 is regarded a promising target for tumor therapy. [23] [24] [25] However, its involvement in the control of numerous cellular processes may cause adverse side effects of such treatments. The identification of miR-21 as a Stat3 target gene may provide an even more selective and promising target for future therapeutic strategies.
